Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases
UK guidelines recommend monitoring clinical response and full blood count (typically at around 2 months) to ensure treatment adequacy, rather than routinely rechecking B12 levels after replacement has started
Target Fucoidan supports the metabolic shift that directs the body toward using abdominal fat as fuel
It appears to be very potent, meaning that very low doses can be used, and this is scalable
With frequent use, or in the context of alcohol intake, chronic illness, pregnancy, or nutrient depletion, its impact on liver health, oxidative stress, detoxification capacity, and immune development becomes far more significant